Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does Ticagrelor Improve Graft Patency After Coronary Bypass?

NCT02053909 is registered in ClinicalTrials.gov with Boca Raton Regional Hospital as lead sponsor.

NCT NCT02053909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02053909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does Ticagrelor Improve Graft Patency After Coronary Bypass?
Lead sponsor
Boca Raton Regional Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
August 31, 2021
Enrollment
250 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

saphenous vein graft disease